Graves’ disease and Hashimoto’s thyroiditis are the two most common autoimmune thyroid disorders — and they push the thyroid in opposite directions. Understanding the difference explains why symptoms and treatments differ so completely.
Same mechanism, opposite result
Both conditions involve the immune system attacking the thyroid — but the target and result differ:
| Graves’ disease | Hashimoto’s thyroiditis | |
|---|---|---|
| Antibody target | TSH receptor (stimulating) | Thyroid peroxidase (TPO) |
| Effect | Overstimulates → excess hormone | Destroys tissue → hormone falls |
| Result | Hyperthyroidism | Hypothyroidism |
| Typical symptoms | Weight loss, palpitations, anxiety, heat intolerance | Fatigue, weight gain, cold intolerance, constipation |
| Key test | TRAb positive | Anti-TPO positive |
| Treatment | Antithyroid drugs, RAI, surgery | Lifelong levothyroxine |
Graves’ disease: the stimulating antibody
In Graves’, antibodies called TRAb bind to and activate the TSH receptor — mimicking TSH and driving continuous hormone production. The gland enlarges into a smooth goitre.
Unique features:
- Thyroid eye disease — bulging eyes, double vision (Graves’ orbitopathy)
- Pretibial myxedema — skin thickening over shins (rarer)
- Can remit — ~50% achieve remission after 12–18 months of antithyroid drugs
Hashimoto’s thyroiditis: the destructive process
In Hashimoto’s, lymphocytes infiltrate the thyroid and produce anti-TPO antibodies, gradually damaging hormone-producing cells. The gland may enlarge early (goitre) then shrink over years.
- Progressive — hormone output declines slowly over years
- Usually permanent — once hypothyroid, lifelong levothyroxine is needed
- Can have transient hyperthyroid phase — as stored hormone leaks from inflamed tissue
Can they coexist or convert?
Rarely — some patients have both antibody types, and Hashimoto’s can occasionally convert to Graves’ (or vice versa), though this is uncommon. Both can occur in the same family, reflecting shared genetic susceptibility.
The bottom line
Despite both being “autoimmune thyroid disease,” Graves’ and Hashimoto’s are clinically distinct — different antibodies, different hormone patterns, different treatments. Correct antibody testing (TRAb vs anti-TPO) is what separates them — which is why proper diagnosis matters before treatment begins.